Both human and mouse expression data (Fig. 1b–g) do not indicate whether SLC16A13 deregulation is causal or just a consequence of metabolic alterations in the context of obesity. Here, SLC16A13 is linked to obesity due to melanocortin 4 receptor deficiency.